Hohimer Wealth Management LLC Sells 24 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Hohimer Wealth Management LLC reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 0.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,476 shares of the healthcare conglomerate’s stock after selling 24 shares during the quarter. UnitedHealth Group accounts for 1.0% of Hohimer Wealth Management LLC’s portfolio, making the stock its 27th largest position. Hohimer Wealth Management LLC’s holdings in UnitedHealth Group were worth $3,936,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of UNH. Richelieu Gestion SA bought a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $26,000. CGC Financial Services LLC increased its stake in UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after buying an additional 50 shares during the last quarter. LFA Lugano Financial Advisors SA boosted its stake in shares of UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after buying an additional 40 shares during the last quarter. O Brien Wealth Partners LLC increased its position in shares of UnitedHealth Group by 36.8% in the fourth quarter. O Brien Wealth Partners LLC now owns 78 shares of the healthcare conglomerate’s stock valued at $41,000 after acquiring an additional 21 shares during the last quarter. Finally, Friedenthal Financial bought a new position in UnitedHealth Group in the fourth quarter valued at approximately $42,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. Royal Bank of Canada lowered their target price on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a report on Wednesday, April 17th. TD Cowen reduced their price target on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a report on Wednesday, April 10th. HSBC raised UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price objective for the company in a research report on Thursday, April 4th. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Monday, May 13th. Finally, Stephens reiterated an “overweight” rating and issued a $605.00 price objective on shares of UnitedHealth Group in a report on Thursday, February 8th. Three investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus price target of $570.05.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.33% of the stock is owned by insiders.

UnitedHealth Group Price Performance

Shares of UNH stock traded down $5.19 during trading on Thursday, hitting $516.16. The company had a trading volume of 1,752,084 shares, compared to its average volume of 4,172,018. The firm has a market capitalization of $475.07 billion, a P/E ratio of 31.64, a price-to-earnings-growth ratio of 1.52 and a beta of 0.55. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85. The stock’s 50-day moving average price is $488.32 and its 200 day moving average price is $511.06. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same quarter in the previous year, the firm earned $6.26 earnings per share. UnitedHealth Group’s revenue for the quarter was up 8.6% compared to the same quarter last year. Equities analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.46%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is presently 45.97%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.